Abstract:Forecasting of severe acute graft-versus-host disease (aGVHD) after transplantation is a challenging ‘large p, small n’ problem that suffers from nonuniform data sampling. We propose a dynamic probabilistic algorithm, daGOAT, that accommodates sampling heterogeneity, integrates multidimensional clinical data and continuously updates the daily risk score for severe aGVHD onset within a two-week moving window. In the studied cohorts, the cross-validated area under the receiver operator characteristic curve (AURO… Show more
“…Like previous reports,25 26 we affirmed that younger age and higher lymphocyte count were associated with earlier viral clearance. The multidimensional approach in this study echoes recent advances in phenotypic analysis in other diseases 27–29…”
Section: Discussionmentioning
confidence: 76%
“…The multidimensional approach in this study echoes recent advances in phenotypic analysis in other diseases. [27][28][29] It has been well documented that prolonged isolation-either in residential compounds or at a medical facility-may lead to mental distress. 1 30 During the study period, several measures were undertaken to minimise mental distress and financial burden for the PCR-positive cases: First, family members were treated in the same room whenever possible.…”
ObjectiveTo report how the Chinese mainland battled its first omicron wave, which happened in Tianjin, a metropolis with 14 million residents. We also sought to better understand how clinical features affected the timing of viral clearance.DesignA retrospective study of the omicron wave in Tianjin between 8 January 2022 and 3 March 2022.SettingExcept for the first cases on 8 January, all the omicron cases were identified through PCR mass testing in the residential communities. Residential quarantine and serial PCR mass testing were dynamically adjusted according to the trends of new cases.ParticipantsAll the 417 consecutive PCR-positive cases identified through mass screening of the entire city’s 14 million residents. 45.3% of the cases were male, and the median age was 37 (range 0.3–90). 389 (93%) cases had complete data for analysing the correlation between clinical features and the timing of viral clearance.Main outcome and measureTime to viral clearance.ResultsTianjin initiated the ‘dynamic zero-COVID’ policy very early, that is, when daily new case number was ≈0.4 cases per 1 000 000 residents. Daily new cases dropped to <5 after 3 February, and the number of affected residential subdivisions dropped to ≤2 after 13 February. 64% (267/417) of the cases had no or mild symptoms. The median interval from hospital admission to viral clearance was 10 days (range 3–28). An exploratory analysis identified a feature cluster associated with earlier viral clearance, with HRs of 3.56 (95% CI 1.66 to 7.63) and 3.15 (95% CI 1.68 to 5.91) in the training and validation sets, respectively.ConclusionsThe ‘dynamic zero-COVID’ policy can suppress an omicron wave within a month. It might be possible to predict in advance which cases will require shorter periods of isolation based on their clinical features.
“…Like previous reports,25 26 we affirmed that younger age and higher lymphocyte count were associated with earlier viral clearance. The multidimensional approach in this study echoes recent advances in phenotypic analysis in other diseases 27–29…”
Section: Discussionmentioning
confidence: 76%
“…The multidimensional approach in this study echoes recent advances in phenotypic analysis in other diseases. [27][28][29] It has been well documented that prolonged isolation-either in residential compounds or at a medical facility-may lead to mental distress. 1 30 During the study period, several measures were undertaken to minimise mental distress and financial burden for the PCR-positive cases: First, family members were treated in the same room whenever possible.…”
ObjectiveTo report how the Chinese mainland battled its first omicron wave, which happened in Tianjin, a metropolis with 14 million residents. We also sought to better understand how clinical features affected the timing of viral clearance.DesignA retrospective study of the omicron wave in Tianjin between 8 January 2022 and 3 March 2022.SettingExcept for the first cases on 8 January, all the omicron cases were identified through PCR mass testing in the residential communities. Residential quarantine and serial PCR mass testing were dynamically adjusted according to the trends of new cases.ParticipantsAll the 417 consecutive PCR-positive cases identified through mass screening of the entire city’s 14 million residents. 45.3% of the cases were male, and the median age was 37 (range 0.3–90). 389 (93%) cases had complete data for analysing the correlation between clinical features and the timing of viral clearance.Main outcome and measureTime to viral clearance.ResultsTianjin initiated the ‘dynamic zero-COVID’ policy very early, that is, when daily new case number was ≈0.4 cases per 1 000 000 residents. Daily new cases dropped to <5 after 3 February, and the number of affected residential subdivisions dropped to ≤2 after 13 February. 64% (267/417) of the cases had no or mild symptoms. The median interval from hospital admission to viral clearance was 10 days (range 3–28). An exploratory analysis identified a feature cluster associated with earlier viral clearance, with HRs of 3.56 (95% CI 1.66 to 7.63) and 3.15 (95% CI 1.68 to 5.91) in the training and validation sets, respectively.ConclusionsThe ‘dynamic zero-COVID’ policy can suppress an omicron wave within a month. It might be possible to predict in advance which cases will require shorter periods of isolation based on their clinical features.
“…In recent years, there has been growing interest in devising new computational methods for analyzing multidimensional phenotypes in diseases (for instance, acute respiratory distress syndrome, 30 type 2 diabetes, 31 aGVHD, 32 and sepsis 33 ). For post‐transplant immune reconstitution, Toor et al have developed the methodology of using logistic dynamics to classify the temporal profiles of the total lymphocyte count post‐transplant into three distinct growth patterns, 21 Koenig et al have explored the application of principal component analysis to measure the distance between an HSCT patient's immune status and the immune status of non‐hematological patients and the use of this distance for predicting overall survival, 10 and Mellgren et al have proposed to use reflected discriminant analysis to decompose post‐transplant immune reconstitution into two independent axes (one for cell normalization and the other for functional maturation).…”
Section: Discussionmentioning
confidence: 99%
“…For 420 (21.6% of 1945) of the patients in SKIRT, the multivariate time‐series of ≥159 clinical features during the initial 100 days post‐transplant and their peri‐transplant characteristics such as patient age, patient sex, primary diagnosis, transplant type, and stem cell source have been published elsewhere. 32 The computational code used in this study is available in a public GitHub repository ( https://github.com/chenjunren-ihcams/SKIRT ).…”
There has been little consensus on how to quantitatively assess immune reconstitution after hematopoietic stem cell transplantation (HSCT) as part of the standard of care. We retrospectively analyzed 11 150 post‐transplant immune profiles of 1945 patients who underwent HSCT between 2012 and 2020. 1838 (94.5%) of the cases were allogeneic HSCT. Using the training set of patients (n = 729), we identified a composite immune signature (integrating neutrophil, total lymphocyte, natural killer, total T, CD4+ T, and B cell counts in the peripheral blood) during days 91–180 after allogeneic HSCT that was predictive of early mortality and moreover simplified it into a formula for a Composite Immune Risk Score. When we verified the Composite Immune Risk Score in the validation (n = 284) and test (n = 391) sets of patients, a high score value was found to be associated with hazard ratios (HR) of 3.64 (95% C.I. 1.55–8.51; p = .0014) and 2.44 (95% C.I., 1.22–4.87; p = .0087), respectively, for early mortality. In multivariate analysis, a high Composite Immune Risk Score during days 91–180 remained an independent risk factor for early mortality after allogeneic HSCT (HR, 1.80; 95% C.I., 1.28–2.55; p = .00085). In conclusion, the Composite Immune Risk Score is easy to compute and could identify the high‐risk patients of allogeneic HSCT who require targeted effort for prevention and control of infection.
“…Liu et al [66 ▪▪ ] devised a multidimensional probabilistic model called daGOAT that integrates multidimensional time-series data – including vital signs, CBCs, routine serum chemistries, electrolytes, cytokines, flow cytometric data, and antibodies – to calculate the risk for severe acute GVHD. The accuracy of daGOAT was compared to two landmark-specific plasma biomarker-based models (the two-biomarker MAGIC score and the three-biomarker Ann arbor score), two peri-transplantation features-based models (‘PeriHSCT-Naïve Bayes or ‘PeriHSCT-Random Forest), and XGBoost (a gradient-boosting tree algorithm).…”
Section: Predicting the Risk Of Graft-versus-host Diseasementioning
Purpose of review
This review delves into the potential of artificial intelligence (AI), particularly machine learning (ML), in enhancing graft-versus-host disease (GVHD) risk assessment, diagnosis, and personalized treatment.
Recent findings
Recent studies have demonstrated the superiority of ML algorithms over traditional multivariate statistical models in donor selection for allogeneic hematopoietic stem cell transplantation. ML has recently enabled dynamic risk assessment by modeling time-series data, an upgrade from the static, “snapshot” assessment of patients that conventional statistical models and older ML algorithms offer. Regarding diagnosis, a deep learning model, a subset of ML, can accurately identify skin segments affected with chronic GVHD with satisfactory results. ML methods such as Q-learning and deep reinforcement learning have been utilized to develop adaptive treatment strategies (ATS) for the personalized prevention and treatment of acute and chronic GVHD.
Summary
To capitalize on these promising advancements, there is a need for large-scale, multicenter collaborations to develop generalizable ML models. Furthermore, addressing pertinent issues such as the implementation of stringent ethical guidelines is crucial before the widespread introduction of AI into GVHD care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.